Quantcast
Channel: News - EpiVax, Inc. - Informatics and Immunology
Browsing all 110 articles
Browse latest View live

URI Accepting Fellows for NTD Vaccine Design Toolkit and Training Workshop...

PROVIDENCE, R.I. – March 26, 2015 – The University of Rhode Island’s Institute for Immunology and Informatics is currently accepting fellows to participate in a workshop and training course targeting...

View Article



Testimony on Faster, Safer, More Effective Vaccines by Dr. Annie De Groot to...

Anne De Groot, CEO of EpiVax, will testify before the Blue Ribbon Study Panel on Biodefense about encouraging innovative methods for solving existing and new biothreats. View a PDF of Annie’s...

View Article

Image may be NSFW.
Clik here to view.

5th Computational Vaccinology Workshop (CV5) at ISV

We invite you to join us for this year’s iteration of the Computational Vaccinology Workshop @ ISV. Register for this event! Abstract submissions for full-length papers and posters are still being...

View Article

Image may be NSFW.
Clik here to view.

$5.2 Million Department of Defense Grant Awarded to “Vaccine on Demand”...

VaxCelerate Team PROVIDENCE, RI – June 9, 2015 – The Defense Threat Reduction Agency (DTRA) is investing $5.2 Million for the development of a new type of vaccine against Q fever. Academic and industry...

View Article

Image may be NSFW.
Clik here to view.

Immune Camouflage – Immune System Achilles’ Heel

Why Epitope Redundancy Provides Resiliency and Weakness What we learn about ourselves will be good for future treatment of autoimmune disease, and what we learn about our pathogen enemies will lead to...

View Article


Exploring the Link between Polio Vaccination and Hand Foot Mouth Disease

The Centre for Health Protection (CHP) of the China Department of Health is investigating an outbreak of hand, foot and mouth disease (HFMD) at a residential child care center in Causeway Bay, Hong...

View Article

Designing the future at EpiVax

A new, optimized vaccine for H7N9 flu could soon move into production. PROVIDENCE – Getting into the clinic has always been a bit of a stumbling block for EpiVax, a creative vaccine design firm...

View Article

Flublok, the first recombinant flu vaccine, reshapes the market

MERIDEN, Conn. – Another flu season is fast approaching, and with it, concerns about the potential effectiveness of flu vaccines to combat two strains of flu virus expected to be in circulation, it...

View Article


Image may be NSFW.
Clik here to view.

Where in the World is EpiVax?

Having a hard time keeping up with the EpiVaxer’s?   Click HERE for more information about where we will be in September & October! September 10th-17th→Tokyo, Japan •Friday, September 11th: EpiVax...

View Article


Image may be NSFW.
Clik here to view.

9th Vaccine Renaissance: Call for Abstracts

CALL FOR ABSTRACTS 9th Vaccine Renaissance Conference Providence, RI – November 4-6, 2015 The 9th Annual Vaccine Renaissance Conference planning committee is pleased to invite you to submit an abstract...

View Article

H7N9 Vaccine weakness due to Immune Camouflage

Researchers at EpiVax and University of Rhode Island explain H7N9 influenza vaccine failure: Pathogen developed ‘Immune Camouflage’ to hide from human immune response The avian influenza A(H7N9) virus...

View Article

Back to the Future: iCubed (URI) hosts its 9th Vaccine Renaissance Conference

Even though Ebola has faded into the background, newly emerging infectious disease remain a challenge for the future. Completely new vaccines to prevent infectious diseases, and ancient ones, will be...

View Article

A BioBetter Botulinum

Ipsen and EpiVax have announced the completion of a collaborative project that resulted in a “stealth” version of a botulinum neurotoxin derived therapeutic. As foreign proteins, BoNTs have the...

View Article


Blue Ribbon Biodefense Panel Recommends Vaccines-on-Demand Approach

October 28th – Providence, RI – A report released today by former DHS Secretary Tom Ridge, former US Senator Joseph Lieberman and members of the Blue Ribbon Study Panel on Biodefense (BRSPB) identified...

View Article

EpiVax vaccine technologies get big boost

A new blue ribbon study, “A National Blueprint for Biodefense,” endorsed a new strategic direction for medical countermeasures to biothreats, recommending investments in vaccine-on-demand technologies...

View Article


Image may be NSFW.
Clik here to view.

EpiVax Accelerating Innovation, Growth

From left: Cliff Grimm (MD) and Bill Martin (CIO) Seventeen years ago EpiVax Inc. spun out of a laboratory at Brown University – a high-risk but high-reward company whose founders had made an...

View Article

Raimondo Works to Spark Innovation Economy

Rhode Island offers companies access to research and development to help them grow PROVIDENCE, R.I. – Governor Gina M. Raimondo, along with Secretary of Commerce Stefan Pryor, today launched three new...

View Article


Image may be NSFW.
Clik here to view.

A Computational Pipeline for Personalized Cancer Vaccines

A short time ago, we received an email that contained an individual patient’s cancer genome. The patient had appealed to his doctor to make a personalized cancer vaccine, and his doctor emailed us, to...

View Article

EpiVax Spins Out Aceno Biotherapeutics at JP Morgan/Biotech Showcase 2016

PROVIDENCE, R.I., Jan. 11, 2016 /PRNewswire/ — EpiVax, Inc. (EpiVax) today announced the company’s participation in a new venture, Aceno Biotherapeutics, a BioSuperior company. Co-founder Anne S. De...

View Article

Image may be NSFW.
Clik here to view.

The Immune System Achilles’ Heel

An academic version of this blog post, that explains why epitope redundancy provides resiliency (to bacteria) and weakness (to immune defense) can be found here.  . . . So a guy named Elledge has...

View Article
Browsing all 110 articles
Browse latest View live




Latest Images